Hand Repair Niche PONTiS specializes in upper and lower extremity bone and soft tissue repair with an FDA‑approved hand tendon/ligament repair system, signaling a strong fit for hand surgeons and specialized orthopedic centers. Target hospital‑based hand clinics, provide clinician education and training, and develop early adopters and case studies to drive clinical adoption.

Early Stage Growth As a small team with revenue in the under‑$1M range, PONTiS can accelerate through strategic distributor partnerships, contract manufacturers and OEM collaboration to scale commercialization. Focus on channel partners, pilots in select centers, and joint go‑to‑market plans to expand reach without heavy internal overhead.

US FDA Advantage FDA approval and product release for hand repair create a credible US market entry point. Leverage regulatory status in marketing to hospitals and surgical centers, pursue real‑world evidence and training programs to shorten adoption cycles and support expansion into adjacent upper or lower extremity applications.

Strategic Partnerships Given the small size, pursue partnerships with larger OEMs or orthopedic distributors to access established sales forces, training capabilities, and global reach. Consider licensing or co‑development opportunities to broaden instrument sets and accelerate commercialization.

Clinical Adoption Path Prioritize building clinical data, KOL engagement, and robust training programs to drive surgeon confidence and routine usage. Develop case studies, procedural videos, and cost‑benefit analyses to demonstrate value against established competitors.